+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant

Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant

Chembiochem 12(5): 761-767

Glycosaminoglycans (GAGs), particularly heparin, are known to reduce the toxicities of various amyloidogenic proteins. The molecular factors underlying the antitoxic effects of GAGs, however, are still not fully understood. Because interactions of amyloidogenic proteins and their aggregates with membranes are believed to play major roles in affecting amyloid pathogenesis, our objective in this study was to elucidate the effect of heparin on membrane interactions of the 21-residue amyloidogenic determinant of the prion protein [PrP(106-126)]. Indeed, the experimental results indicate that heparin significantly interferes in membrane interactions of the prion peptide. Specifically, we show that there is direct competition for binding of PrP(106-126) between heparin on the one hand and negatively charged phospholipids on the other hand. The data reveal that heparin, even in very low molar concentrations, exhibited high affinity towards PrP(106-126) and consequently suppressed interactions of the peptide with lipid vesicles. Interestingly, whereas heparin significantly inhibited lipid-induced PrP(106-126) fibrillation, it still promoted fibril formation in aqueous solutions independently of the lipid vesicles present. Our results strongly suggest that the primary effects of GAGs in attenuating amyloid toxicities are due to blocking of membrane interactions of the amyloidogenic proteins rather than modulation of their fibrillation properties.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053513160

Download citation: RISBibTeXText

PMID: 21337481

DOI: 10.1002/cbic.201000486

Related references

Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant. Chembiochem 11(14): 1997-2002, 2010

Phospholipid-induced fibrillation of a prion amyloidogenic determinant at the air/water interface. Langmuir 25(21): 12501, 2009

Bacoside-A, an anti-amyloid natural substance, inhibits membrane disruption by the amyloidogenic determinant of prion protein through accelerating fibril formation. Biochimica et Biophysica Acta 1858(9): 2208-2214, 2016

Lipid-induced calcitonin fibrillation blocks membrane interactions of a peptide antibiotic. Journal of Physical Chemistry. B 114(47): 15530, 2010

Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions. Journal of Molecular Biology 392(1): 198-207, 2009

A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes. Journal of Biological Chemistry 289(43): 30144-30160, 2014

Amyloidogenic properties of the prion protein fragment PrP185-208 Comparison with Alzheimers peptide A beta1-28, influence of heparin and cell toxicity. Biochemical and Biophysical Research Communications 368(2): 238-242, 2008

Impact of SDS surfactant on the interactions of Cu(2+) ions with the amyloidogenic region of human prion protein. Dalton Transactions 44(29): 13125-13132, 2015

Extensive diversity of prion strains is defined by differential chaperone interactions and distinct amyloidogenic regions. Plos Genetics 10(5): E1004337, 2014

Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin. Febs Letters 587(6): 569-574, 2013

Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization. Biosensors and Bioelectronics 26(4): 1399-1406, 2010

Lipid bilayers significantly modulate cross-fibrillation of two distinct amyloidogenic peptides. Journal of the American Chemical Society 135(36): 13582, 2013

Copper-induced structural propensities of the amyloidogenic region of human prion protein. Journal of Biological Inorganic Chemistry 19(4-5): 635-645, 2014

Interaction of human laminin receptor with Sup35, the [PSI⁺] prion-forming protein from S. cerevisiae: a yeast model for studies of LamR interactions with amyloidogenic proteins. Plos one 9(1): E86013, 2014